scholarly journals The role of nitric oxide in treatment of acute lung injury after surgery with extracorporeal circulation

2003 ◽  
Vol 50 (2) ◽  
pp. 49-54 ◽  
Author(s):  
R. Sindjelic ◽  
G. Vlajkovic ◽  
Miljko Ristic ◽  
I. Divac ◽  
D. Markovic

Postoperative acute lung injury (ALI) compromises oxygen transfer across alveolar-capillary membrane with consecutive hypoxia, one of its indicators being reduction of oxygenation index PaO2/FiO2 below 40 kPa (300 mm Hg). Management of ALI includes different procedures like mechanical lung ventilation (MLV), drugs and others. One of the new possibilities for treatment of ALI is nitric oxide (NO) inhalation. The aim of this prospective study was to examine the role of NO inhalation in treatment of ALI. 14 patients with ALI developed immediately after operation with extracorporeal circulation (ECC) were included in the study. Group A (n = 8) inhaled NO and group B (n = 6) did not inhale NO during treatment of ALI. All other therapeutic measures were the same in both groups. The groups were similar in relation to demographic data, type of surgery and duration of ECC. PaO2/FiO2 was calculated before operation (T1), immediately after surgery (T2) and after lung recovery, when the need for MLV stopped (T3). The duration of MLV was also registered. PaO2/FiO2 (kPa) in referent times was in group A 54,9 ? 1,6, 33,8 ? 1,2 and 46,2 ? 0,8 and in group B 52,2 ? 1,1, 33,5 ? 1,5 and 47,3 ? 0,9, respectively. There was a statistically significant decrease of PaO2/FiO2 in T2 and T3 vs T1 in both groups (p < 0,05), while the difference between the groups was not statistically significant. The duration of MLV (h) in group B (28,5 ? 1,6) was statistically significantly shorter than in group A (63,1 ? 8,7) (p < 0,01). According to the results of this study we conclude that NO inhalation during ALI after surgery with ECC significantly reduces the duration of MVL and improves pulmonary recovery .

Shock ◽  
2004 ◽  
Vol 21 (Supplement) ◽  
pp. 78 ◽  
Author(s):  
Debra L. Laskin ◽  
Diane E. Heck ◽  
Jeffrey D. Laskin

Shock ◽  
2003 ◽  
Vol 20 (6) ◽  
pp. 569-574 ◽  
Author(s):  
Rachid Zegdi ◽  
Olivier Fabre ◽  
Mich??le Cambillau ◽  
Paul Forn??s ◽  
Khalid A. Tazi ◽  
...  

2000 ◽  
Vol 93 (3A) ◽  
pp. A-456
Author(s):  
Kyoung M. Lee ◽  
Hee U. Kwon ◽  
Kong B. Im ◽  
Jong T. Park ◽  
No Kwak

2012 ◽  
Vol 131 (2) ◽  
pp. 612-628 ◽  
Author(s):  
Wenli Li ◽  
Fangfang Liu ◽  
Chen Wang ◽  
Hubert Truebel ◽  
Juergen Pauluhn

2021 ◽  
Vol 2021 ◽  
pp. 1-22
Author(s):  
Yiru Shao ◽  
Zhifeng Jiang ◽  
Daikun He ◽  
Jie Shen

Phosgene exposure can cause acute lung injury (ALI), for which there is no currently available effective treatment. Mesenchymal stem cells (MSCs) which have been proven to have therapeutic potential and be helpful in the treatment of various diseases, but the mechanisms underlying the function of MSCs against phosgene-induced ALI are still poorly explored. In this study, we compared the expression profiles of mRNAs, lncRNAs, and circRNAs in the lung tissues from rats of three groups—air control (group A), phosgene-exposed (group B), and phosgene + MSCs (group C). The results showed that 389 mRNAs, 198 lncRNAs, and 56 circRNAs were differently expressed between groups A and B; 130 mRNAs, 107 lncRNAs, and 35 circRNAs between groups A and C; and 41 mRNAs, 88 lncRNAs, and 18 circRNAs between groups B and C. GO and KEGG analyses indicated that the differentially expressed RNAs were mainly involved in signal transduction, immune system processes, and cancers. In addition, we used a database to predict target microRNAs (miRNAs) interacting with circRNAs and the R network software package to construct a circRNA-targeted miRNA gene network map. Our study showed new insights into changes in the RNA expression in ALI, contributing to explore the mechanisms underlying the therapeutic potential of MSCs in phosgene-induced ALI.


1994 ◽  
Vol 1 ◽  
pp. 475
Author(s):  
H. Manabe ◽  
T. Yoshikawa ◽  
T. Yamaguchi ◽  
H. Yamamoto ◽  
Y. Nakahashi ◽  
...  

2002 ◽  
Vol 23 ◽  
pp. S51
Author(s):  
K. Murakami ◽  
P. Enkhbaatar ◽  
K. Shimoda ◽  
A. Chandra ◽  
D. N. Herndon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document